C1q/TNF-related protein-1: an adipokine marking and promoting atherosclerosis

Lin Lu1, Rui Yan Zhang2, Xiao Qun Wang1

  • 1Department of Cardiology, Rui Jin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, People's Republic of China Institute of Cardiovascular Diseases, Shanghai Jiaotong University School of Medicine, Shanghai 200025, People's Republic of China.

European Heart Journal
|December 26, 2015
PubMed

Insights

C1q/TNF-related protein-1 (CTRP1) is elevated in coronary artery disease (CAD) patients and promotes atherosclerosis by increasing inflammation and monocyte adhesion. CTRP1 is a potential therapeutic target for preventing CAD progression.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Molecular Medicine

Background:

  • Coronary artery disease (CAD) is a significant global health burden.
  • Adipokines, like C1q/TNF-related protein (CTRP) 1, play roles in metabolic and cardiovascular health.
  • The specific role of CTRP1 in the pathogenesis of CAD requires further elucidation.

Purpose of the Study:

  • To investigate the association between CTRP1 levels and CAD in humans.
  • To determine the biological effects of CTRP1 on vascular cells and its role in atherogenesis.
  • To explore CTRP1 as a potential biomarker and therapeutic target for CAD.

Main Methods:

  • Analysis of CTRP1 serum levels in CAD patients and controls.
  • Immunohistochemical assessment of CTRP1 expression in human atherosclerotic tissues.
  • In vitro studies on CTRP1's effects on endothelial cells and monocytes.
  • In vivo studies using mouse models (apoE-/- and CTRP1-/-/apoE-/-) to assess CTRP1's role in atherogenesis.

Main Results:

  • CTRP1 levels were significantly higher in CAD patients' sera and atherosclerotic tissues compared to controls.
  • CTRP1 induced inflammatory markers and adhesion molecules in vascular cells, promoting monocyte-endothelial adhesion.
  • CTRP1 administration promoted atherogenesis in apoE-/- mice, an effect attenuated in CTRP1 deficient mice.
  • CTRP1 deficiency reduced inflammatory responses and macrophage infiltration in atherosclerotic plaques.

Conclusions:

  • CTRP1 is a novel biomarker associated with CAD severity.
  • CTRP1 actively promotes atherogenesis through inflammatory pathways and leukocyte recruitment.
  • Targeting CTRP1 may offer a therapeutic strategy for mitigating atherosclerosis and CAD progression.
Abstract

Related Concept Videos

Inflammation01:38

Inflammation

Overview
46.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
2.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K